Experience with UFT in Japan

ONCOLOGY

Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 30-34

  Taguchi, Tetsuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; TEGAFUR; UFT;

ANEMIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DOSE CALCULATION; DRUG ERUPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; LEUKOPENIA; MALAISE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PIGMENTATION; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DRUG COMBINATIONS; HUMANS; JAPAN; NEOPLASMS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0030777707     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Hiller SA, Juk RA, Lidak MYU, et al: Analogs of pyrimidine nucleosides. Dokl Akad Nauk SSSR 176:332-335, 1967.
2. Fujii S, Ikenaka K, Fukushima M, et al: Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 69:763-772, 1978.
3. Taguchi T, Nakano H, Jikuya H, et al: Effect of uracil on the antitumor activity of Ftorafur. Jpn J Cancer Chemollier 5:1161 -1165, 1978.
4. Taguchi T, Furue H, Koyama Y, et al: Phase I study of UFT. Jpn J Cancer Cliemotlier 7:966-972, 1980.
5. Nakajima O, Ihara K, Isoda T, et al: Phase I and II studies on mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil. Jpn J Cancer Cliemotlier 7:1558-1568, 1980.